Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Chang Chun Plastics Co. Ltd. has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 examiners and 2 art units, reflecting separate examination assignments within the active docket.
BOYLE, ROBERT C is the busiest examiner, with 1 pending matter. Each matter therefore calls for attention to its assigned examiner and art unit rather than a single shared prosecution approach.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOYLE, ROBERT C | 1 | 69.7% | -2.8% |
| DESTEFANO, AUDRA JEAN | 1 | 57.5% | +57.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18401857 | ALLYL-CONTAINING BISPHENOL RESIN | BOYLE, ROBERT C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18143622 | MELAMINE-FORMALDEHYDE RESIN COMPOSITION, COATING COMPOSITION COMPRISING THE SAME, COATING LAYER, AND ITS APPLICATION | DESTEFANO, AUDRA JEAN | 9d overdue |
| Art Unit | Apps |
|---|---|
| 1623 | 1 |
| 1766 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18401857 | ALLYL-CONTAINING BISPHENOL RESIN | BOYLE, ROBERT C | 1623 | §102§112 | Non-Final OA | — | Pending | Jan 02, 2024 |
| 18143622 | MELAMINE-FORMALDEHYDE RESIN COMPOSITION, COATING COMPOSITION COMPRISING THE SAME, COATING LAYER, AND ITS APPLICATION | DESTEFANO, AUDRA JEAN | 1766 | §103 | Final Rejection | 9d overdue | Pending | May 05, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialChang Chun Plastics Co. Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Robert C Boyle has the most, with 1 of Chang Chun Plastics Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
